Symposium
Practising personalised medicine: why, when, and how?
Clinical
Aims : To provide novel clinical insights in personalised medicine strategies for important pulmonary diseases, describe new and promising concepts relating to these diseases for the near future and discuss the impact of these developments on clinical practice and healthcare system finances.
10:45
COPD: can we improve treatment?
A. Agusti Garcia-Navarro(Barcelona, Spain)
COI
1
445
11:15
Asthma: are we already there?
I. Pavord(Oxford (Oxfordshire), United Kingdom)
COI
2
446
11:45
Pneumonia: one size fits all?
B. Schmeck(Marburg, Germany)
COI
3
447
12:15
Pulmonary hypertension: what can we learn from studies?
M. Humbert(Le Kremlin-Bicêtre, France)
COI
4
448
. . .
